| Pharmaceutical active ingredients: |
| Bevacizumab |
| Available forms, composition and doses of Antivegf: |
| N / A |
| Antivegf medical category: |
| Human:Antineoplastic agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XC07 - Bevacizumab |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Antihypertonicum S | Betula; Crataegus; Mistletoe; Olive; Proxyphylline; Rhododendron Leaf; Rutin | Schuck |
| Solubitrat | Betula; Equisetum; Fennel Oil; Java Tea; Juniper Oil; Solidago Virgaurea | Pfizer |
| Betullosin | Betula; Hamamelis; Lidocaine Hydrochloride; Resorcinol | Vis Farmaceutici Istituto Scientifico delle Venezie |
| Rheumadrag | Betula; Salicylamide; Sodium Gentisate; Urtica; Vitamin B1 (Thiamine Hydrochloride) | Schuck |
| Blasen Nieren Tee | Betulae; Couch Grass; Liquorice; Ononis; Solidago Virgaurea | Stada |
| Avastatin | Bevacizumab | Roche |
| Avastin | Bevacizumab | Roche; DKSH; Firma Chun Cheong; Genentech; Institute of Pharmaceutical Research and Technology; Zuellig Pharma |
| Ranestol | Bevantolol Hydrochloride | Pfizer |
| Ranezide | Bevantolol Hydrochloride; Hydrochlorothiazide | Pfizer |
| Tranquirax | Bevonium Metilsulfate; Medazepam | Sanofi-Aventis |